NCT05497765View on ClinicalTrials.gov

An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease

NACompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

January 31, 2024

Study Completion Date

February 20, 2024

Conditions
Nonalcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

Silibinin extract, mixed power of pueraria, schisandra and salvia miltiorrhiza

Take 4 tablets with warm water twice a day

DIETARY_SUPPLEMENT

Silibinin extract

Take 4 tablets with warm water twice a day

DIETARY_SUPPLEMENT

Placebo

Take 4 tablets with warm water twice a day

Trial Locations (1)

523808

Department of Nutrition, School of Public Health, Guangdong Medical University, Dongguan

All Listed Sponsors
collaborator

Affiliated Hospital of Guangdong Medical University

OTHER

lead

Guangzhou Medical University

OTHER